Companies: 10,795·Total market cap: $144.5T
X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc.

XFORNASDAQHealthcare● Active
$3.88
+$0.17(+4.58%)
Market Cap$365960420
P/E Ratio
52W High$4.83
52W Low$1.35
Overview

X4 Pharmaceuticals, Inc.(XFOR)· 资产负债表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · XFOR · 截至 2026-06-10

财务报表

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$253.00M$102.06M$114.22M$121.72M$81.79M
Net Receivables$0.57M$1.71M$0.56M$1.15M$0.75M
Inventory$4.48M$2.82M$0.00M$0.00M$0.00M
Total Current Assets$261.58M$112.17M$122.08M$128.68M$87.88M
PP&E Net$1.59M$4.84M$6.39M$8.33M$10.22M
Goodwill$17.35M$17.35M$17.35M$17.35M$17.35M
Intangible Assets$9.25M$10.00M$0.00M$0.00M$0.00M
Total Assets$290.46M$146.45M$147.26M$155.59M$117.18M
Liabilities
Short-Term Debt$0.00M$0.00M$0.00M$1.31M$1.87M
Accounts Payable$5.70M$8.62M$8.95M$7.78M$4.28M
Total Current Liabilities$25.76M$32.88M$22.86M$22.32M$14.02M
Long-Term Debt$76.29M$75.42M$54.57M$32.30M$33.14M
Total Liabilities$104.17M$124.30M$96.16M$81.53M$52.76M
Stockholders Equity
Retained Earnings($594.55M)($515.36M)($477.90M)($376.74M)($282.87M)
Total Stockholders Equity$186.29M$22.15M$51.10M$74.05M$64.41M
Total Liab & Equity(computed)$290.46M$146.45M$147.26M$155.59M$117.18M
Debt Summary
Total Debt$77.28M$78.09M$58.28M$38.42M$39.78M
Net Debt($139.76M)$22.39M($40.94M)($83.30M)($42.00M)

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解X4 Pharmaceuticals, Inc.

关于X4 Pharmaceuticals, Inc.(XFOR)资产负债表

X4 Pharmaceuticals, Inc.总资产$0.29B,现金及短期投资$0.25B,总负债$0.10B,总债务$0.08B,股东权益$0.19B。

常见问题

XFOR · 4 问

X4 Pharmaceuticals, Inc.总债务$0.08B,净债务($0.14B)。

XFOR total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10